|Title:||Use of 3,3'-azo-bis-(6-hydroxy benzoic acid) as a drug and pharmaceutical compositions containing the same|
|Abstract:||A method of treating inflammatory diseases such as ulcerous colitis, comprising administration of 3,3'-azo-bis-(6-hydroxy benzoic acid) of the formula: ##STR1## or pharmaceutically acceptable salts thereof. Pharmaceutical compositions, especially for oral administration, contain said compound, or pharmaceutically acceptable salts thereof, together with pharmaceutically acceptable carriers and/or adjuvants.|
|Inventor(s):||Agback; Karl H. (Uppsala, SE), Natvig; Tore (Uppsala, SE), Truelove; Sidney C. (Kirtlington, GB2)|
|Assignee:||Pharmacia AB (Uppsala, SE)|
Patent Claim Types:|
see list of patent claims
|Use; Dosage form; Composition;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Sweden||8002322||Mar 26, 1980|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.